The Organisation for Economic Co-operation and Development (OECD) has recently published the first five adverse outcome pathways (AOP), three of which have been developed by the JRC. The AOPs are novel knowledge management tools in toxicology and are useful for supporting risk assessment to human health. They are also valuable for helping to avoid animal testing through the use of alternative methods.
An adverse outcome pathway, or AOP, is a highly structured way of describing a toxicological process which can lead to an adverse health effect in humans or wildlife, caused by an unsafe exposure to a chemical substance. Essentially an AOP tells a toxicological story in terms of a logical sequence of causally-linked ‘key events’ that occur at different levels of biological organisation, from perturbations at the molecular scale up to effects occurring in a whole organism or a population. The AOPs developed by the JRC, now published by OECD, relate to chemical-induced liver fibrosis, aspects of neurotoxicity in adults, and certain neurotoxicological effects that can be caused during human development.
AOP development process
The AOP framework has been developed through an extensive international collaboration between scientists, regulators and policy-makers with the primary goal of making mechanistic toxicological knowledge more readily available to support safety assessment decisions. AOPs are essential in the process of shifting from traditional animal testing to new non-animal approaches that are based on the combination of in vitro methods and computational modelling. The AOPs are available in the new OECD Series on Adverse Outcome Pathways. The development process followed the relevant OECD guidance.
At the OECD, the Extended Advisory Group for Molecular Screening and Toxicogenomics (co-chaired by the JRC on behalf of the EU) manages the development of AOPs which undergo a series of expert reviews before being submitted for endorsement to the Working Group of National Coordinators for the Test Guidelines Programme (WNT) and the Task Force for Hazard Assessment. Although the AOPs developed until now have addressed chemical toxicity, the approach also lends itself to describing the mechanistic basis to potential adverse effects caused by nanomaterials, as demonstrated very recently by the JRC.
AOP Knowledge Base
The JRC has also partnered with the OECD and the US Environmental Protection Agency to develop the publically accessible AOP Knowledge Base. This key resource facilitates the scientific crowdsourcing and on-line peer review foreseen in the AOP development process and allows an AOP to continue to evolve as understanding of the underlying science grows. Once an AOP reaches a certain level of maturity, it is versioned as a document and published in the new OECD series to encourage its utilisation in non-animal species-relevant approaches to regulatory safety assessment.
This novel knowledge management framework, which is already transforming the world of toxicology, has the potential to penetrate other fields such as biomedical research, where effective translation of mechanistic understanding into application is central to innovation and progress.
Learn more: Advancing non-animal testing methods: first set of novel knowledge tools published
The Latest on: Non-animal testing methods
[google_news title=”” keyword=”non-animal testing methods” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Non-animal testing methods
- University of Manchester animal testing at a seven-year highon May 8, 2024 at 6:06 am
The University of Manchester conducted research and testing on more than 100,000 animals last year, new figures show. A freedom ...
- CTPA calls on UK government for dedicated animal-free chemical testing strategyon May 2, 2024 at 7:37 am
UK trade association, the Cosmetic, Toiletry and Perfumery Association (CTPA) , is calling on the UK government to publish a dedicated Non-Animal New Approach M ...
- Procter and Gamble descendant proposes bill to stop the type of animal testing P&G has doneon May 2, 2024 at 1:42 am
A descendant of the founders of Procter and Gamble, a multi-billion dollar consumer goods company, is proposing legislation in the Ohio House to stop cosmetics testing on animals. P&G, although saying ...
- Procter and Gamble heiress proposes bill to stop the type of animal testing P&G has doneon April 30, 2024 at 3:42 pm
The heiress of Procter and Gamble is proposing legislation in the Ohio House to stop cosmetics testing on animals.
- Opinion: It’s time to stop product and science testing on animalson April 24, 2024 at 3:44 am
Science has given us many marvels. Electricity immediately springs to mind, as does the telephone. The remarkable ease with which we’re able to trace our ancestry is utterly astounding, and ...
- World Day for Animals in Laboratories: Why animal testing should be bannedon April 24, 2024 at 12:10 am
Animal-testing activists have come a long way in advocating for countries to ban animal-testing, and in doing so, many local and international brands have hopped on the bandwagon, finding alternative ...
- Council Approves Narrow Animal Testing Banon April 19, 2024 at 7:50 am
Such testing often determines whether a drug ... rules for implementing the Act nor established guidelines for non-animal test methods. Researchers and advocates are pushing the FDA to develop ...
- Will Young's animal testing petition explainedon October 11, 2023 at 8:37 am
He continued: ‘Given the low scientific value of these experiments, combined with major advances in non-animal methods (NAMs), we believe testing on dogs should be banned, in the same way as for ...
- Experimenting on animalson November 30, 2021 at 12:48 am
They also agree that it's wrong to use animals if alternative testing methods would produce equally ... To the undecided (and non-prejudiced) the answer is, of course, obvious.
via Bing News